Connect with us

Hi, what are you looking for?


Illumina Rises On Forecast Of $1 Billion Revenues In Q1, Analyst Retaining Buy

Stock Markets48 minutes ago (Apr 06, 2021 08:23AM ET)

(C) Reuters.

By Dhirendra Tripathi – Shares of gene-sequencing company Illumina (NASDAQ:ILMN) were up 11% in Tuesday’s premarket after the company indicated its revenue had topped $1 billion revenues in the quarter through March.

The revenue forecast for the quarter is 26% higher than last year’s. For fiscal year 2021, Illumina now expects year-over-year revenue growth in the range of 25%-28% compared to fiscal year 2020.

Illumina credited record orders in the gene-sequencing and related businesses for its optimistic outlook.

Illumina president and chief executive officer Francis deSouza said its sequencing technology is helping attract demand for Covid-19-related surveillance globally.

Canaccord Genuity analyst Max Masucci on Monday maintained a ‘buy’ rating on the Nasdaq-listed company, setting a price target of $460, almost 20% higher than its closing level on Monday.

Masucci expects Illumina to post earnings per share of $1.76 for the second quarter of 2021.

The current consensus among 9 TipRanks analysts is for a ‘moderate buy’ rating of shares in Illumina, with an average price target of $441.56.The analysts’ price targets range between $285 and $570.

Illumina Rises On Forecast Of $1 Billion Revenues In Q1, Analyst Retaining Buy

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt.


Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione.


Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum.


At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores.

Disclaimer: it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial or health advice. Copyright © 2021 Buzz Clever. All Rights Reserved